MBA INCORPORADO SL

Their core work

MBA Incorporado is a private company based in Gijón, in the heart of Asturias — Spain's traditional industrial region — that participates in applied R&D consortia as a specialist partner. Their H2020 track record spans two distinct domains: marine biotechnology (specifically the extraction and application of marine biomolecules that inhibit biofilm formation on medical devices) and sustainable advanced manufacturing through powder metallurgy process optimization. This unusual combination suggests a company with diversified technical capabilities or consultancy functions that allow them to contribute meaningfully to projects in quite different sectors. Their industrial base in Asturias likely underpins their manufacturing credentials, while their marine biotech involvement points to broader applied science capabilities.

What they specialise in

How they've shifted over time

With only two projects — NOMORFILM starting in 2015 and SUPREME in 2017, and both running through to 2019–2020 — MBA Incorporado's H2020 participation represents a brief, overlapping window rather than a long evolutionary arc. Their first engagement was in blue biotechnology and biomedical applications; their second moved into advanced manufacturing and materials science. Whether this reflects a strategic pivot or simply opportunistic project participation is unclear from the data alone. No keyword data is available to confirm technical depth in either direction.

With activity ending around 2020 and no further H2020 projects, it is unclear whether they continued R&D engagement in either domain — a potential partner should verify current activity before pursuing collaboration.

How they like to work

MBA Incorporado has always entered H2020 as a participant, never as coordinator, which positions them as a specialist contributor rather than a consortium driver. Despite only two projects, they accumulated 38 unique partners across 14 countries — suggesting participation in large, multi-partner RIA and IA consortia typical of EU-wide research calls. This breadth of network relative to project count implies they are comfortable operating within complex, international partnerships without taking the lead.

MBA Incorporado has worked with 38 unique partners spanning 14 countries across just two projects — a notably wide network for such a limited project portfolio, reflecting the large consortium structures of RIA and IA funding schemes. No geographic concentration is evident from the data, suggesting broad European reach rather than a focus on Iberian or regional partners.

What sets them apart

MBA Incorporado occupies an unusual position as a private company (not a university or research institute) that has contributed to both marine biotechnology and advanced metal manufacturing — two sectors that rarely share consortium membership. Based in Gijón, a city with deep roots in heavy industry and steel, their manufacturing credentials have a plausible industrial foundation. For a consortium builder, they represent a private-sector Spanish partner with cross-sector applied R&D experience, though the limited project history means their specific technical contribution within each consortium remains opaque.

Highlights from their portfolio

• NOMORFILM
  Highest-funded project (€295,000) and the more technically distinctive engagement — marine biomolecules applied to medical device biofilm prevention is a niche intersection of blue biotech and healthcare.
• SUPREME
  Demonstrates cross-sector versatility: a powder metallurgy manufacturing project represents a completely different domain from NOMORFILM, showing the company's willingness to contribute across industrial and biotech consortia.